[HTML][HTML] Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)

R Seifert, L Emmett, SP Rowe, K Herrmann… - European Urology, 2023 - Elsevier
Context Prostate-specific membrane antigen (PSMA) targeting positron emission
tomography (PET) is emerging to become a reference imaging tool for the staging and …

Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for …

KM Chow, WZ So, HJ Lee, A Lee, DWT Yap… - European urology, 2023 - Elsevier
Context Whether prostate-specific membrane antigen positron emission tomography (PSMA-
PET) should replace conventional imaging modalities (CIM) for initial staging of intermediate …

PET/MRI in prostate cancer: a systematic review and meta-analysis

L Evangelista, F Zattoni, G Cassarino, P Artioli… - European journal of …, 2021 - Springer
Aim In recent years, the clinical availability of scanners for integrated positron emission
tomography (PET) and magnetic resonance imaging (MRI) has enabled the practical …

Comparison of biparametric and multiparametric mri for clinically significant prostate cancer detection with PI‐RADS version 2.1

T Tamada, A Kido, A Yamamoto… - Journal of Magnetic …, 2021 - Wiley Online Library
Background Biparametric MRI (bpMRI) without dynamic contrast‐enhanced MRI (DCE‐MRI)
results in an elimination of adverse events, shortened examination time, and reduced costs …

Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a histopathology gold standard in the detection, intraprostatic localization, and determination of …

I Sonni, ER Felker, AT Lenis, AE Sisk… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The role of prostate-specific membrane antigen (PSMA)–targeted PET in comparison to
multiparametric MRI (mpMRI) in the evaluation of intraprostatic cancer foci is not well …

What's behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression …

JH Rüschoff, DA Ferraro, UJ Muehlematter… - European Journal of …, 2021 - Springer
Purpose Prostate-specific membrane antigen (PSMA-) PET has become a promising tool in
staging and restaging of prostate carcinoma (PCa). However, specific primary tumour …

[HTML][HTML] [68Ga] Ga-PSMA-11 in prostate cancer: a comprehensive review

F Bois, C Noirot, S Dietemann, IC Mainta… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool
for managing patients with recurrent prostate cancer, and one of the most frequently …

Prostate-specific membrane antigen PET in prostate cancer

C Lawhn-Heath, A Salavati, SC Behr, SP Rowe… - Radiology, 2021 - pubs.rsna.org
Prostate-specific membrane antigen (PSMA)–targeted radiopharmaceuticals are playing a
large role at the time of initial staging and biochemical recurrence for localizing prostate …

The impact of positron emission tomography imaging and tumor molecular profiling on risk stratification, treatment choice, and oncological outcomes of patients with …

A Sood, AU Kishan, CP Evans, FY Feng… - European Urology …, 2024 - Elsevier
Context The clinical introduction of next-generation imaging methods and molecular
biomarkers (“radiogenomics”) has revolutionized the field of prostate cancer (PCa). While …

International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology

P Veit-Haibach, H Ahlström, R Boellaard… - European journal of …, 2023 - Springer
Abstract Preamble The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an
international scientific and professional organization founded in 1954 to promote the …